T‐Cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1423-0410|108|1|82-88

ISSN： 0042-9007

Source： VOX SANGUINIS, Vol.108, Iss.1, 2015-01, pp. : 82-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Cutaneous T‐cell Lymphomas (CTCL) with Extracorporeal Photochemotherapy

By  

THE JOURNAL OF DERMATOLOGY, Vol. 17, Iss. 12, 1990-12 ,pp. : 737-745

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases

By  

Transfusion Medicine and Hemotherapy, Vol. 35, Iss. 1, 2007-12 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

U.K. national audit of extracorporeal photopheresis in cutaneous T‐cell lymphoma

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 569-570

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Clinical Applications of Extracorporeal Photochemotherapy

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 2, 2015-04 ,pp. : 103-110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 30, Iss. 3, 2015-06 ,pp. : 162-170

John Wiley & Sons Inc

Access to resources Recommend Favorite